COMMUNIQUÉS West-GlobeNewswire

Initiation of new share buyback program
01/05/2019
Based on the continued solid business performance and GN’s capital structure policy and in accordance with the authorization granted to the Board of Directors at the annual general meeting on 21 March 2019, GN announces [...]
Veteran With Spinal Injury to Throw Out First Pitch at Diamondbacks Game Tuesday Thanks to SoldierStrong-Donated Exoskeleton
01/05/2019
PHOENIX, April 30, 2019 (GLOBE NEWSWIRE) -- Dan Rose, a former U.S. Army sergeant paralyzed by an 1,100-pound bomb in Afghanistan in 2011, will throw out the first pitch at Tuesday's Arizona Diamondbacks-New York [...]
SoldierStrong Donates State-of-the-Art Exoskeleton to the Veterans Affairs Phoenix Health Care System
01/05/2019
PHOENIX, April 30, 2019 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit organization dedicated to providing advanced medical technologies to veterans, donated an EksoGT Suit exoskeleton to the Phoenix Veterans [...]
À l'occasion de l'assemblée générale annuelle de l'American Society of Gene and Cell Therapy, Abeona Therapeutics présentera de nouvelles données précliniques démontrant le potentiel thérapeutique d'ABO-401 pour le traitement de la fibrose kystique
01/05/2019
NEW YORK et CLEVELAND, 01 mai 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), un chef de file totalement intégré en thérapie génique et cellulaire, présentera aujourd'hui de nouvelles données [...]
Nabriva Therapeutics Receives Complete Response Letter from FDA on NDA for Intravenous CONTEPO™ (fosfomycin) for injection
01/05/2019
Issues related to facility inspections and manufacturing deficiencies at one contract manufacturer Conference call and webcast tomorrow at 8:00 a.m. EDT DUBLIN, Ireland, April 30, 2019 (GLOBE NEWSWIRE) -- Nabriva [...]
Repligen Corporation Prices Public Offering of Shares of Common Stock
01/05/2019
WALTHAM, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced the pricing of an underwritten public offering of 2,734,375 shares of its common stock at a public offering price of [...]
Golden Leaf Reports Fiscal Year 2018 Results
01/05/2019
Reported Record Annual Revenue of US$16.5 million TORONTO, April 30, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE:GLH) (OTCQB:GLDFF) (“Golden Leaf” or the “Company”), a leading cannabis company built around [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2019
CAMBRIDGE, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on April 30, 2019, that were previously [...]
Better Choice Company Inc. Announces $14.8 Million Private Placement
30/04/2019
BROOKLYN, N.Y., April 30, 2019 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (OTCQB: BTTR) (the “Company”) today announced that it has entered into definitive agreements to sell securities to certain accredited [...]
EVE & CO Reports Financial Results for the Fourteen Month Period ended December 31, 2018
30/04/2019
TORONTO, April 30, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to report the filing of its audited financial results for the fourteen month [...]
STERIS to Host a Conference Call for Fiscal 2019 Fourth Quarter and Full Year Financial Results on May 14, 2019
30/04/2019
DUBLIN, Ireland, April 30, 2019 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2019 fourth quarter and full year [...]
DiaMedica Therapeutics to Present at CKD3 Kidney Summit Meeting
30/04/2019
MINNEAPOLIS, April 30, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biotechnology company, today announced that Dr Harry Alcorn, its Chief Medical Officer will be presenting “ [...]
New data at AAN reinforce Novartis commitment to transforming the lives of people of all ages who live with neurological conditions
30/04/2019
Novartis leads the way at AAN with 53 abstracts, showcasing its broad portfolio of transformative medicines and innovative solutions for people living with spinal muscular atrophy (SMA), multiple sclerosis (MS) and [...]
Eton Pharmaceuticals to Report First Quarter 2019 Financial Results on Tuesday, May 7, 2019
30/04/2019
DEER PARK, Ill., April 30, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that [...]
Amedisys Reports First Quarter 2019 Financial Results and Reaffirms 2019 Guidance
30/04/2019
BATON ROUGE, La., April 30, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2019. Three Month Periods Ended March 31, 2019 and 2018 [...]
BeyondSpring Files 2018 Annual Report on Form 20-F
30/04/2019
NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it has filed its annual [...]
MRI Interventions Reports 52% Increase in First Quarter Revenue
30/04/2019
Record $2.5 million quarterly revenue driven by growth across entire portfolio IRVINE, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC) (the “Company”) today announced financial results [...]
Prothena to Report First Quarter 2019 Financial Results on May 7
30/04/2019
DUBLIN, Ireland, April 30, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, will announce financial results for the first quarter of 2019 on May 7, 2019 after the [...]
Paratek Pharmaceuticals to Report First Quarter 2019 Financial Results on May 8, 2019
30/04/2019
BOSTON, April 30, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK ), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]

Pages